[{"NetIncomeLoss_3_Q3_USD":-79273000.0,"OperatingLeaseLiability_0_Q3_USD":3496000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":8.44,"GeneralAndAdministrativeExpense_3_Q3_USD":29211000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":10549000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":84413511.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":97920460.0,"CommitmentsAndContingencies_0_Q3_USD":null,"GainLossOnSaleOfPropertyPlantEquipment_3_Q3_USD":0.0,"AccruedLiabilitiesCurrent_0_Q3_USD":13281000.0,"PreferredStockValueOutstanding_0_Q3_USD":0.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_3_Q3_USD":714000.0,"ValueAddedTaxReceivableCurrent_0_Q3_USD":0.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":467000.0,"DeferredCosts_0_Q3_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":175578000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-115000.0,"Depreciation_3_Q3_USD":43000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":2602268.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":483000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":689000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":1132000.0,"AssetsCurrent_0_Q3_USD":429428000.0,"OperatingLeaseExpense_3_Q3_USD":700000.0,"OperatingLeaseExpense_1_Q3_USD":200000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":5982712.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":725000.0,"DueToRelatedPartiesCurrent_0_Q3_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":1152000.0,"CommonStockSharesIssued_0_Q3_shares":97971243.0,"IncomeTaxesPaid_3_Q3_USD":166000.0,"ProceedsFromContributedCapital_3_Q3_USD":333000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":907000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":2392000.0,"BusinessCombinationAcquisitionRelatedCosts_3_Q3_USD":2800000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":295000.0,"ClassOfWarrantOrRightOutstanding_0_Q3_shares":0.0,"ResearchAndDevelopmentExpense_3_Q3_USD":49989000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":21091000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":15.73,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":3824000.0,"IncreaseDecreaseInPrepaidExpense_3_Q3_USD":1513000.0,"RepaymentsOfConvertibleDebt_3_Q3_USD":0.0,"AccruedBonusesCurrent_0_Q3_USD":2085000.0,"PrepaidExpenseCurrent_0_Q3_USD":6973000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":2590000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-352000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-503000.0,"Liabilities_0_Q3_USD":18877000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":-279000.0,"NumberOfReportableSegments_3_Q3_segment":1.0,"CommonStockValue_0_Q3_USD":10000.0,"ForeignCurrencyTransactionGainLossUnrealized_3_Q3_USD":-483000.0,"IncreaseDecreaseInDueToRelatedPartiesCurrent_3_Q3_USD":0.0,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.0035,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":0.0114,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":382349000.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":1236000.0,"CommonStockNoParValue_0_Q3_USD":0.0001,"ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0_Q3_shares":0.0,"ProceedsFromNotesPayable_3_Q3_USD":0.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-78790000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-31087000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":421974000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":-367000.0,"Assets_0_Q3_USD":433029000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":483000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":689000.0,"WriteOffOfDeferredDebtIssuanceCost_3_Q3_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":5757732.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":1372915.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-170499000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":321403000.0,"CommonStockSharesOutstanding_0_Q3_shares":97971243.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_3_Q3_shares":226233.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_3_Q3_USD":7.86,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":5992000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":689000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-60831000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":1198000.0,"LiabilitiesCurrent_0_Q3_USD":16485000.0,"AccountsPayableCurrent_0_Q3_USD":2100000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":115000.0,"InterestExpense_3_Q3_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":421974000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":224000.0,"RelatedPartyTransactionAmountsOfTransaction_3_Q3_USD":700000.0,"RelatedPartyTransactionAmountsOfTransaction_1_Q3_USD":200000.0,"StockIssued1_3_Q3_USD":0.0,"AdditionalPaidInCapital_0_Q3_USD":584174000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":114084.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"OperatingLeasePayments_3_Q3_USD":700000.0,"OperatingLeasePayments_1_Q3_USD":500000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":51828000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":132000.0,"NetIncomeLoss_1_Q3_USD":-31776000.0,"InterestExpense_1_Q3_USD":0.0,"StockholdersEquity_0_Q3_USD":414152000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.32,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.94,"ShareBasedCompensation_3_Q3_USD":13334000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":3469000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":10875718.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":16.94,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":17.81,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q3_USD":30.65,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":328000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":47000.0,"IncreaseDecreaseInAccountsPayableTrade_3_Q3_USD":914000.0,"CommonStockSharesAuthorized_0_Q3_shares":500000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q3_shares":4893006.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3_Q3_USD":-79552000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q3_USD":-32143000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_3_Q3_USD":0.0,"IncomeTaxesReceivable_0_Q3_USD":481000.0,"IncreaseDecreaseInIncomeTaxesReceivable_3_Q3_USD":445000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":4183000.0,"OperatingExpenses_1_Q3_USD":31640000.0,"OperatingExpenses_3_Q3_USD":79200000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1104000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":378107.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":48900000.0,"ConvertiblePreferredStockSharesReservedForFutureIssuance_0_Q3_shares":10000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":5992000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":433029000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":8.57,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":25.92,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q3_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":13217000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":1445000.0,"Ticker":"IMVT","CIK":"1764013","name":"IMMUNOVANT, INC.","OfficialName":"Immunovant Inc. Common Stock","form":"10-Q","period":"20201231","fy":"2021.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"407422400.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210216"}]